Azenta (AZTA) | Financial Analysis & Statements
Financial Overview
Latest Annual: 2024Income Metrics
Revenue
656.3M
Gross Profit
263.4M
40.13%
Operating Income
-72.9M
-11.11%
Net Income
-164.2M
-25.01%
EPS (Diluted)
-$3.09
Balance Sheet Metrics
Total Assets
2.1B
Total Liabilities
331.1M
Shareholders Equity
1.8B
Debt to Equity
0.19
Cash Flow Metrics
Operating Cash Flow
-62.8M
Free Cash Flow
12.9M
Revenue & Profitability Trend
Azenta Income Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 656.3M | 665.1M | 555.5M | 513.7M | 388.5M |
| Cost of Goods Sold | 393.0M | 401.9M | 299.9M | 269.9M | 216.4M |
| Gross Profit | 263.4M | 263.1M | 255.6M | 243.8M | 172.1M |
| Operating Expenses | 336.3M | 350.2M | 279.0M | 274.5M | 208.1M |
| Operating Income | -72.9M | -87.1M | -23.4M | -30.7M | -35.9M |
| Pre-tax Income | -167.3M | -30.4M | -9.9M | -49.0M | -40.3M |
| Income Tax | -3.2M | -17.6M | 1.4M | -20.1M | -13.9M |
| Net Income | -164.2M | -14.3M | 2.1B | 110.7M | 64.9M |
| EPS (Diluted) | -$3.09 | -$0.22 | $28.48 | $1.49 | $0.88 |
Income Statement Trend
Azenta Balance Sheet From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | 832.8M | 1.4B | 2.5B | 777.4M | 649.5M |
| Non-Current Assets | 1.3B | 1.5B | 1.3B | 1.0B | 909.8M |
| Total Assets | 2.1B | 2.9B | 3.7B | 1.8B | 1.6B |
| Liabilities | |||||
| Current Liabilities | 204.8M | 210.9M | 230.5M | 345.1M | 211.1M |
| Non-Current Liabilities | 126.2M | 140.3M | 122.2M | 149.1M | 134.5M |
| Total Liabilities | 331.1M | 351.2M | 352.7M | 494.2M | 345.7M |
| Equity | |||||
| Total Shareholders Equity | 1.8B | 2.5B | 3.4B | 1.3B | 1.2B |
Balance Sheet Composition
Azenta Cash Flow Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -164.2M | -14.3M | 2.1B | 110.7M | 64.9M |
| Operating Cash Flow | -62.8M | 29.5M | 2.1B | 127.7M | 116.7M |
| Investing Activities | |||||
| Capital Expenditures | -37.4M | -39.4M | -73.4M | -52.8M | -39.9M |
| Investing Cash Flow | 224.7M | 431.4M | 1.5B | -146.3M | -22.7M |
| Financing Activities | |||||
| Dividends Paid | 0 | 0 | -7.5M | -29.7M | -29.5M |
| Financing Cash Flow | -659.2M | -840.5M | -62.8M | -25.9M | -27.0M |
| Free Cash Flow | 12.9M | -32.3M | -543.5M | 97.1M | -2.1M |
Cash Flow Trend
Azenta Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
-10.80
Forward P/E
79.79
Price to Book
0.90
Price to Sales
2.29
PEG Ratio
79.79
Profitability Ratios
Profit Margin
-9.77%
Operating Margin
-8.77%
Return on Equity
-8.58%
Return on Assets
-1.66%
Financial Health
Current Ratio
3.22
Debt to Equity
3.16
Beta
1.61
Per Share Data
EPS (TTM)
-$3.27
Book Value per Share
$37.17
Revenue per Share
$13.95
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| azta | 1.5B | -10.80 | 0.90 | -8.58% | -9.77% | 3.16 |
| Intuitive Surgical | 189.7B | 77.39 | 11.09 | 15.96% | 28.41% | 0.00 |
| Becton, Dickinson | 50.0B | 33.87 | 1.98 | 5.89% | 7.18% | 76.34 |
| Lemaitre Vascular | 1.9B | 42.77 | 5.48 | 13.77% | 19.96% | 53.33 |
| AtriCure | 1.6B | - | 3.46 | -8.38% | -7.95% | 17.03 |
| Pulse Biosciences | 1.1B | -18.29 | 9.24 | -77.86% | 0.00% | 7.24 |
Financial data is updated regularly. All figures are in the company's reporting currency.